New Japanese patent approval for Episurf Medical
The Japanese patent office JPO has announced its intention to grant another Japanese patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint”, is within the area of 3D-based assessment of joint lesions. “This is a core patent for Episurf’s medical imaging technology, and we are happy to get it approved in strategically selected countries”, says Katarina Flodström, COO, Episurf Medical. For more information, please contact: Pål Ryfors, CEO, Episurf MedicalTel:+46 (0)